Skip to main content

Device Options in the Cath Lab: Practical Patient Support

Joseph L. Thomas, MD, FSCAI
Assistant Health Science Clinical Professor David Geffen School of Medicine Director, Interventional Cardiology Harbor-UCLA Medical Center


The use of percutaneous mechanical circulatory support (MCS) has been rapidly evolving as devices become smaller, more efficient, easier to deploy, and less invasive. The purpose of this session is to share an expert’s experience on the use of counterpulsation therapy in the treatment of a patient at high risk for cardiovascular compromise during percutaneous coronary intervention (PCI) considering current evidence, risk of complication, and cost.

Learning objectives

  1. Review current data and society recommendations on the use of available percutaneous MCS devices.
  2. Describe real world risk and cost of complications.


Back to Top